Moreover, mutations in NF2 moesin-ezrin-radixin-like (MERLIN) tumor suppressor (NF2/merlin) indirectly disrupt signaling pathways such as RAS, contributing to the formation of tumors like bilateral vestibular schwannomas (Fig. 5a). This evidence concerns the gene NF2 and Vestibular schwannoma.